Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer

समान संसाधन

• Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
  द्वारा: Hoque, Ismoth Ara
  प्रकाशित: (2024)
• Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
  द्वारा: Paul, Pulock
  प्रकाशित: (2024)
• Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
  द्वारा: Rahman, Tasnim
  प्रकाशित: (2024)
• Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
  द्वारा: Flora, Sanzida Alam
  प्रकाशित: (2024)
• Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
  द्वारा: Hasan, Sakib
  प्रकाशित: (2024)